In this study, we report on a novel heteroplasmic pathogenic variant in mitochondrial DNA (mtDNA). The studied patient had myoclonus, epilepsy, muscle weakness, and hearing impairment and harbored a heteroplasmic m.8315A>C variant in the MTTK gene with a mutation load ranging from 71% to >96% in tested tissues. In muscle mitochondria, markedly decreased activities of respiratory chain complex I + III and complex IV were observed together with mildly reduced amounts of complex I and complex V (with the detection of V*- and free F1-subcomplexes) and a diminished level of complex IV holoenzyme. This pattern was previously seen in other MTTK pathogenic variants. The novel variant was not present in internal and publicly available control databases. Our report further expands the spectrum of MTTK variants associated with mitochondrial encephalopathies in adults.

Department of Pediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University and General University Hospital Prague 128 08 Prague Czech Republic

See more in PubMed

Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990;61:931–937. doi: 10.1016/0092-8674(90)90059-N. PubMed DOI

Richter U., McFarland R., Taylor R.W., Pickett S.J. The molecular pathology of pathogenic mitochondrial tRNA variants. FEBS Lett. 2021;595:1003–1024. doi: 10.1002/1873-3468.14049. PubMed DOI PMC

DiMauro S., Schon E.A., Carelli V., Hirano M. The clinical maze of mitochondrial neurology. Nat. Rev. Neurol. 2013;9:429–444. doi: 10.1038/nrneurol.2013.126. PubMed DOI PMC

MITOMAP: A Human Mitochondrial Genome Database 2019. [(accessed on 26 May 2022)]. Available online: http://www.mitomap.org.

Blakely E.L., Alston C.L., Lecky B., Chakrabarti B., Falkous G., Turnbull D.M., Taylor R.W., Gorman G.S. Distal weakness with respiratory insufficiency caused by the m.8344A>G “MERRF” mutation. Neuromuscul. Disord. 2014;24:533–536. doi: 10.1016/j.nmd.2014.03.011. PubMed DOI PMC

Mancuso M., Orsucci D., Angelini C., Bertini E., Carelli V., Comi G.P., Minetti C., Moggio M., Mongini T., Servidei S., et al. Phenotypic heterogeneity of the 8344A>G mtDNA “MERRF” mutation. Neurology. 2013;80:2049–2054. doi: 10.1212/WNL.0b013e318294b44c. PubMed DOI

Makinen M.W., Lee C.P., Shy G.M. Microanalysis of cytochrome content, oxidative and phosphorylative activities of human skeletal muscle mitochondria. Neurology. 1968;18:299. PubMed

Jesina P., Tesarova M., Fornuskova D., Vojtiskova A., Pecina P., Kaplanova V., Hansikova H., Zeman J., Houstek J. Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206. Biochem. J. 2004;383:561–571. doi: 10.1042/BJ20040407. PubMed DOI PMC

Janssen A.J., Trijbels F.J., Sengers R.C., Wintjes L.T., Ruitenbeek W., Smeitink J.A., Morava E., van Engelen B.G., van den Heuvel L.P., Rodenburg R.J. Measurement of the energy-generating capacity of human muscle mitochondria: Diagnostic procedure and application to human pathology. Clin. Chem. 2006;52:860–871. doi: 10.1373/clinchem.2005.062414. PubMed DOI

Rustin P., Chretien D., Bourgeron T., Gerard B., Rotig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta. 1994;228:35–51. doi: 10.1016/0009-8981(94)90055-8. PubMed DOI

Srere P.A., John M.L. Methods in Enzymology. Academic Press; Cambridge, MA, USA: 1969. Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] pp. 3–11.

Schagger H., Cramer W.A., von Jagow G. Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal. Biochem. 1994;217:220–230. doi: 10.1006/abio.1994.1112. PubMed DOI

McCormick E.M., Lott M.T., Dulik M.C., Shen L., Attimonelli M., Vitale O., Karaa A., Bai R., Pineda-Alvarez D.E., Singh L.N., et al. Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation. Hum. Mutat. 2020;41:2028–2057. doi: 10.1002/humu.24107. PubMed DOI PMC

Blakely E.L., Yarham J.W., Alston C.L., Craig K., Poulton J., Brierley C., Park S.M., Dean A., Xuereb J.H., Anderson K.N., et al. Pathogenic mitochondrial tRNA point mutations: Nine novel mutations affirm their importance as a cause of mitochondrial disease. Hum. Mutat. 2013;34:1260–1268. doi: 10.1002/humu.22358. PubMed DOI PMC

Putz J., Dupuis B., Sissler M., Florentz C. Mamit-tRNA, a database of mammalian mitochondrial tRNA primary and secondary structures. RNA. 2007;13:1184–1190. doi: 10.1261/rna.588407. PubMed DOI PMC

Laricchia K.M., Lake N.J., Watts N.A., Shand M., Haessly A., Gauthier L., Benjamin D., Banks E., Soto J., Garimella K., et al. Mitochondrial DNA variation across 56,434 individuals in gnomAD. Genome Res. 2022;32:569–582. doi: 10.1101/gr.276013.121. PubMed DOI PMC

Bolze A., Mendez F., White S., Tanudjaja F., Isaksson M., Jiang R., Rossi A.D., Cirulli E., Rashkin M., Metcalf W., et al. A catalog of homoplasmic and heteroplasmic mitochondrial DNA variants in humans. bioRxiv. 2019 doi: 10.1101/798264. DOI

Mancuso M., Petrozzi L., Filosto M., Nesti C., Rocchi A., Choub A., Pistolesi S., Massetani R., Fontanini G., Siciliano G. MERRF syndrome without ragged-red fibers: The need for molecular diagnosis. Biochem. Biophys. Res. Commun. 2007;354:1058–1060. doi: 10.1016/j.bbrc.2007.01.099. PubMed DOI

Fornuskova D., Brantova O., Tesarova M., Stiburek L., Honzik T., Wenchich L., Tietzeova E., Hansikova H., Zeman J. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim. Biophys. Acta. 2008;1782:317–325. doi: 10.1016/j.bbadis.2008.02.001. PubMed DOI